NCT00002096已完成1 期
A Phase I Pharmacokinetic Study in HIV-Positive Subjects of Oral Ganciclovir and Concomitant Antiretroviral Zidovudine and Didanosine
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 24
- 试验地点
- 6
研究概览
简要总结
To determine whether there is a pharmacokinetic drug interaction between oral ganciclovir and oral zidovudine (AZT) and between oral ganciclovir and oral didanosine (ddI). To determine whether concurrent administration of probenecid affects the pharmacokinetics of oral ganciclovir. To obtain data on the short-term safety of oral ganciclovir administered concurrently with AZT, ddI, or probenecid in HIV-positive patients.
详细描述
Patients currently on either AZT or ddI receive ganciclovir therapy.
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
研究点 (6)
Loading locations...
相似试验
已完成
1 期
Valganciclovir in Congenital CMV InfantsCytomegalovirus InfectionsNCT00031434National Institute of Allergy and Infectious Diseases (NIAID)24
已完成
1 期
A Randomized Comparative Pharmacokinetic Study of Oral Ganciclovir After Treatment With Intravenous Ganciclovir for Cytomegalovirus Gastrointestinal Disease in AIDS PatientsHIV InfectionsColitisNCT00000768National Institute of Allergy and Infectious Diseases (NIAID)24
已完成
1 期
The Rilpivirine Cerebrospinal-fluid (CSF) StudyHIVNCT01562886Imperial College London14
已完成
不适用
A Study of AZT Plus Ganciclovir in Patients With AIDS and Cytomegalovirus (CMV) InfectionCytomegalovirus InfectionsHIV InfectionsNCT00000995National Institute of Allergy and Infectious Diseases (NIAID)60
已完成
1 期
A Phase I Pharmacokinetic and Tolerance Study of 28-Day Regimens of Oral GanciclovirCytomegalovirus RetinitisHIV InfectionsNCT00000668National Institute of Allergy and Infectious Diseases (NIAID)48